Evolus, Inc. (EOLS) Ownership
EOLS ownership summary
as of October 18, 2026- Institutions
- 77.4% of shares outstanding
- Insiders
- 11.25% of shares outstanding
- Shares outstanding
- 66.1M
- Float
- 49.8M shares available to trade
- Short interest
- 8.63% 5.6M shares short
- Days to cover
- 7.64 short interest up 1.8% vs prior month
- Institutions 77.42%
- Insiders 11.25%
- Other investors 11.33%
EOLS top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | 16.96% | 11.2M | $79.5M | +4.8M (+75.7%) | June 30, 2026 |
| 2 | BlackRock Inc | 7.33% | 4.8M | $34.4M | +550,445 (+12.8%) | June 30, 2026 |
| 3 | BRAIDWELL LP | 4.78% | 3.2M | $22.4M | +50,000 (+1.6%) | June 30, 2026 |
| 4 | Frazier Life Sciences Management, L.P. | 3.98% | 2.6M | $18.7M | — | June 30, 2026 |
| 5 | Perceptive Advisors LLC | 3.72% | 2.5M | $17.5M | +1.2M (+91.1%) | June 30, 2026 |
| 6 | Vanguard Capital Management, LLC | 3.58% | 2.4M | $16.8M | −107,515 (−4.4%) | June 30, 2026 |
| 7 | Assenagon Asset Management SA | 2.75% | 1.8M | $12.9M | +1.2M (+203.7%) | June 30, 2026 |
| 8 | Millennium Management LLC | 2.71% | 1.8M | $12.7M | +326,770 (+22.4%) | June 30, 2026 |
| 9 | State Street Corp | 2.57% | 1.7M | $12.1M | +376,504 (+28.5%) | June 30, 2026 |
| 10 | Geode Capital Management, LLC | 2.44% | 1.6M | $11.4M | +227,056 (+16.4%) | June 30, 2026 |
| 11 | Stonepine Capital Management Llc | 2.41% | 1.6M | $11.3M | −168,929 (−9.6%) | June 30, 2026 |
| 12 | Point72 Asset Management, L.P. | 2.28% | 1.5M | $10.7M | +1.5M (0.0%) | June 30, 2026 |
| 13 | Pinnacle Associates Inc | 2.25% | 1.5M | $10.6M | +328,369 (+28.3%) | June 30, 2026 |
| 14 | Armistice Capital, LLC | 2.17% | 1.4M | $10.2M | +40,000 (+2.9%) | June 30, 2026 |
| 15 | Rice Hall James & Associates, LLC | 1.95% | 1.3M | $9.2M | +35,069 (+2.8%) | June 30, 2026 |
| 16 | AWH Capital, L.P. | 1.89% | 1.2M | $8.9M | +625,000 (+100.0%) | June 30, 2026 |
| 17 | The Goldman Sachs Group Inc | 1.85% | 1.2M | $8.7M | +133,021 (+12.2%) | June 30, 2026 |
| 18 | Soleus Capital Management, L.P. | 1.25% | 822K | $5.8M | −1.4M (−63.4%) | June 30, 2026 |
| 19 | Soviero Asset Management, LP | 1.17% | 770K | $5.5M | +89,627 (+13.2%) | June 30, 2026 |
| 20 | UBS Group AG | 1.14% | 753K | $5.3M | −202 (−0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 15 holders added 11.5M shares and 4 cut 1.7M.
EOLS top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Russell 2000 ETF | 2.34% | 1.5M | $11.0M | −17,792 (−1.1%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 2.34% | 1.5M | $11.0M | — | August 31, 2026 |
| 3 | Fidelity Small Cap Index | 0.98% | 646K | $4.6M | +3,241 (+0.5%) | July 31, 2026 |
| 4 | iShares Russell 2000 Growth ETF | 0.82% | 545K | $3.9M | −690 (−0.1%) | September 30, 2026 |
| 5 | State Street® SPDR® S&P® PhrmctlsETF | 0.71% | 472K | $3.3M | −5,862 (−1.2%) | September 30, 2026 |
| 6 | Xtrackers MSCI World Swap ETF 1C | 0.60% | 393K | $2.8M | −2,477 (−0.6%) | December 31, 2025 |
| 7 | Vanguard Russell 2000 ETF | 0.52% | 345K | $2.4M | +3,454 (+1.0%) | September 30, 2026 |
| 8 | Fidelity Extended Market Index | 0.50% | 332K | $2.4M | +3,668 (+1.1%) | August 31, 2026 |
| 9 | Schwab US Small-Cap ETF™ | 0.46% | 306K | $2.2M | +207 (+0.1%) | September 30, 2026 |
| 10 | iShares US Pharmaceuticals ETF | 0.32% | 214K | $1.5M | +659 (+0.3%) | September 30, 2026 |
| 11 | iShares Micro-Cap ETF | 0.28% | 187K | $1.3M | −1,291 (−0.7%) | September 30, 2026 |
| 12 | Schwab Small Cap Index | 0.22% | 144K | $1.0M | — | August 31, 2026 |
| 13 | Vanguard Health Care ETF | 0.22% | 143K | $1.0M | +153 (+0.1%) | September 30, 2026 |
| 14 | Fidelity Total Market Index | 0.19% | 125K | $889,048 | — | August 31, 2026 |
| 15 | Stt Strt SPDR® Russell2000 US SmCapETF | 0.18% | 120K | $849,061 | −8,312 (−6.5%) | September 30, 2026 |
| 16 | Fidelity Nasdaq Composite Index | 0.16% | 106K | $753,992 | +67,558 (+174.8%) | August 31, 2026 |
| 17 | iShares Russell 2000 Small-Cap Idx Instl | 0.16% | 104K | $737,569 | — | August 31, 2026 |
| 18 | Goldman Sachs ActiveBeta® US SmCp Eq ETF | 0.16% | 103K | $728,630 | — | September 30, 2026 |
| 19 | Fidelity Series Total Market Index | 0.15% | 101K | $715,907 | — | August 31, 2026 |
| 20 | Nuveen Small Cap Blend Idx R6 | 0.12% | 79K | $562,533 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
EOLS insider transactions
latest 14| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-20 | David Moatazedi | Sell | $4.75 | 13,669 | $64,928 |
| 2026-03-20 | Rui Avelar | Sell | $4.75 | 3,119 | $14,815 |
| 2026-03-17 | David Moatazedi | Sell | $4.89 | 116,720 | $570,761 |
| 2026-03-17 | Rui Avelar | Sell | $4.89 | 29,996 | $146,680 |
| 2025-12-22 | David Moatazedi | Sell | $7.15 | 10,539 | $75,354 |
| 2025-12-22 | Rui Avelar | Sell | $7.15 | 2,261 | $16,166 |
| 2025-08-22 | Tomoko Yamagishi-Dressler | Sell | $7.51 | 5,722 | $42,972 |
| 2025-08-15 | Brady Stewart | Buy | $6.82 | 30,000 | $204,600 |
| 2025-06-16 | David Moatazedi | Sell | $9.89 | 16,582 | $163,996 |
| 2025-06-13 | David Moatazedi | Sell | $10.05 | 111,323 | $1.1M |
| 2025-06-09 | Albert G White III | Buy | $9.45 | 20,000 | $189,000 |
| 2025-05-13 | Sandra Beaver | Sell | $10.02 | 6,494 | $65,070 |
| 2025-05-12 | David Moatazedi | Sell | $9.87 | 15,787 | $155,818 |
| 2025-05-12 | Rui Avelar | Sell | $9.87 | 3,385 | $33,410 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
EOLS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns EOLS
Institutional investors own 77.4% of Evolus's shares and insiders 11.25%. The largest holder is Nantahala Capital Management, LLC with 16.96% of the shares (11.2M), as of June 30, 2026. Among the top 20 institutions, 15 added shares and 4 reduced their stake in the latest filings. Short interest is 8.63% of the float, or 7.64 days of average trading volume. The share count rose 279.2% since 2015.
Related: EOLS analyst forecast, EOLS key metrics. See the EOLS stock overview for the latest quote and news.
EOLS ownership FAQ
Who owns the most Evolus stock?
The largest shareholders of Evolus are Nantahala Capital Management, LLC (16.96%), BlackRock Inc (7.33%), BRAIDWELL LP (4.78%), Frazier Life Sciences Management, L.P. (3.98%), Perceptive Advisors LLC (3.72%).
What percentage of Evolus is owned by institutions?
Institutions hold 77.4% of Evolus's shares outstanding; insiders hold 11.25%.
Which funds own Evolus?
The largest fund holders of Evolus are iShares Russell 2000 ETF (2.34%), Vanguard MStar Total Stk Mkt Idx Invest (2.34%), Fidelity Small Cap Index (0.98%), iShares Russell 2000 Growth ETF (0.82%), State Street® SPDR® S&P® PhrmctlsETF (0.71%).
What is Evolus's short interest?
5.6M shares of Evolus were sold short, 8.63% of the float; at the average daily volume it would take 7.64 days to cover.
Are insiders buying or selling Evolus?
Of the latest 14 reported insider transactions in Evolus (since May 12, 2025), 2 were purchases and 12 were sales.
How many shares of Evolus are outstanding?
Evolus has 66.1M shares outstanding, of which 49.8M are in the public float.